A Periodical for the Sarcoma Community

June 2009 - Volume 6, Number 3

A Pause to Say "Thank You"

Editorial by Bruce Shriver, PhD

Management in Low-Grade Chondrosarcoma

CTOS Op Ed: Eduardo Novais, MD and R. Lor Randall, MD dicuss one of the most controversial subjects in musculoskeletal tumor surgery - how to manage low-grade chondrosarcomas.

Dermatofibrosarcoma Protuberans (DFSP)

Jonathan Courtney, MD, Richard Gorlick, MD and David Geller, MD review the epidemiology, clinical features, diagnosis, histopathology, treatments, and prognosis of dermatofibrosarcoma protuberans.

Molecular Basis of Genomic Instability in Osteosarcoma

Xin-Yan Lu, MD, Yi-Jue Zhao, MD, Debananda Pati, PhD and Pulivarthi H. Rao, PhD discuss their investigations into the role of CDC5L in the development of genomic instability and progression of osteosarcoma.

Palifosfamide - A Novel Molecule for the Treatment of Soft Tissue Sarcoma (STS): A Primer

Robert Maki, MD, Robert Morgan, and Jonathan Lewis, MD, PhD discuss palifosfamide, a novel molecule being evaluated in soft tissue sarcoma.

Replenishment and Renewal in Patients with Extremity Tumors

Marianne Griffin, RN discusses the effects of sarcoma surgery on quality of life.


$50,000 Grant Awarded for Osteosarcoma Research

The Liddy Shriver Sarcoma Initiative awards a $50,000 grant to researchers at Baylor College of Medicine for the study "Molecular Basis of Genomic Instability in Osteosarcoma."